Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: November 18, 2014
Pages: 26
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OD3A92E6DE9EN
Leaflet:

Download PDF Leaflet

Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a pharmaceutical company. It focuses on developing and manufacturing pharmaceutical solutions including formulations and API products. The company’s product portfolio includes formulations such as cardiovascular products, anti-diabetic products, neuropsychiatry products, nutritional supplements and various other products; and API includes cephalosporins – orals, cephalosporins – injectibles, veterinary products and non-antibiotics. It offers services such as process and pharma research, new drug discovery, pre-clinical research, novel drug delivery systems, biotech research, intellectual property management and contract research and manufacturing services. Orchid’s formulations products serve various therapeutic areas such as cardiovascular, anti-diabetic, central nervous system, anti-infectives, and anti-inflammatory, among others. The company through its subsidiaries, joint ventures and partnerships has operations across 70 countries in the UK, South Africa, the US, Ukraine and others. Orchid is headquartered in Chennai, Tamil Nadu, India.

Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics
Orchid Chemicals & Pharma Enters Into An Agreement With Diakron Pharma
Ranbaxy Labs Enters Into An Agreement With Orchid Chemicals & Pharma
Licensing Agreements
Orchid Chemicals & Pharma Enters Into Licensing Agreement With Alvogen
Merck Enters Into Licensing Agreement With Orchid Chemicals & Pharma
Asset Transactions
Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million
Hospira Completes Acquisition Of Injectable Pharma Business Of Orchid Chemicals & Pharma
Acquisition
NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For US$14 Million
Orchid Chemicals Acquires Karalex Pharma
Orchid Chemicals & Pharmaceuticals Ltd - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2013
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Deals By Therapy Area, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Orchid Chemicals & Pharma Enters Into Co-Development Agreement With Allecra Therapeutics
Orchid Chemicals & Pharma Enters Into An Agreement With Diakron Pharma
Ranbaxy Labs Enters Into An Agreement With Orchid Chemicals & Pharma
Orchid Chemicals & Pharma Enters Into Licensing Agreement With Alvogen
Merck Enters Into Licensing Agreement With Orchid Chemicals & Pharma
Hospira Healthcare Completes Acquisition of Manufacturing and R&D Facility from Orchid Chemicals & Pharma for USD218 Million
Hospira Completes Acquisition Of Injectable Pharma Business Of Orchid Chemicals & Pharma
NCPC To Acquire Remaining 50% Stake In NCPC Orchid Pharma For US$14 Million
Orchid Chemicals Acquires Karalex Pharma
Orchid Chemicals & Pharmaceuticals Ltd, Key Competitors
Orchid Chemicals & Pharmaceuticals Ltd, Key Employees
Orchid Chemicals & Pharmaceuticals Ltd, Other Locations
Orchid Chemicals & Pharmaceuticals Ltd, Subsidiaries

LIST OF FIGURES

Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Orchid Chemicals & Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Skip to top


Ask Your Question

Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: